Satellos Bioscience Inc. (MSLE) — Institutional Holders, Q2 2026

26 institutional investment managers reported a MSLE position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $59.6M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

MSLE in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

3

Added to

6

Trimmed

6

Sold out

7

Biggest buyers

  1. Vivo CapitalNew · +813,666 sh+$6.3M
  2. Stonepine Capital ManagementAdded · +391,624 sh+$3.0M
  3. AWM Investment CompanyNew · +180,000 sh+$1.4M
  4. SPHERA FUNDS MANAGEMENT LTD.Added · +163,383 sh+$1.3M
  5. CITADEL ADVISORSAdded · +25,246 sh+$196.3K

Biggest sellers

  1. ADAGE CAPITAL PARTNERS GP, L.L.C.Trimmed · -230,354 sh-$1.8M
  2. MILLENNIUM MANAGEMENTTrimmed · -145,665 sh-$1.1M
  3. Empery Asset ManagementTrimmed · -123,000 sh-$956.3K
  4. Soleus Capital Management, L.P.Trimmed · -100,000 sh-$777.5K
  5. HRT FINANCIALSold out · -30,461 sh-$236.8K

MSLE 13F holders ranked 1–26 of 26

Institutional investors reporting a position in Satellos Bioscience Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
FRANKLIN RESOURCES#1 · 938,666 sh$7.2M0.0%
Siren, L.L.C.#2 · 892,074 sh$6.9M0.0%
Vivo Capital#3 · 813,666 sh$6.3MNew
Point72 Asset Management, L.P.#4 · 682,700 sh$5.3M-1.2%
SPHERA FUNDS MANAGEMENT LTD.#5 · 652,590 sh$5.1M+33.4%
Woodline Partners#6 · 500,432 sh$3.9M0.0%
Stonepine Capital Management#7 · 491,624 sh$3.7M+391.6%
SUVRETTA CAPITAL MANAGEMENT#8 · 475,000 sh$3.7M0.0%
Avidity Partners Management#9 · 387,769 sh$3.0M0.0%
Saturn V Capital Management#10 · 350,000 sh$2.7M0.0%
Soleus Capital Management, L.P.#11 · 314,359 sh$2.4M-24.1%
683 Capital Management#12 · 230,833 sh$1.8M0.0%
ADAR1 Capital Management#13 · 222,555 sh$1.7M0.0%
AWM Investment Company#14 · 180,000 sh$1.4MNew
MILLENNIUM MANAGEMENT#15 · 152,768 sh$1.2M-48.8%
ADAGE CAPITAL PARTNERS GP, L.L.C.#16 · 150,000 sh$1.2M-60.6%
Empery Asset Management#17 · 107,100 sh$832.7K-53.5%
CITADEL ADVISORS#18 · 67,738 sh$526.7K+59.4%
MORGAN STANLEY#19 · 25,732 sh$200.1K+21.5%
China Universal Asset Management , Ltd.#20 · 20,000 sh$155.5K+212.5%
ROYAL BANK OF CANADA#21 · 15,863 sh$124.0K-2.4%
GEODE CAPITAL MANAGEMENT#22 · 11,907 sh$92.6K0.0%
UBS Group AG#23 · 781 sh$6.1K+2689.3%
JPMORGAN CHASE#24 · 315 sh$2.5KNew
Federation des caisses Desjardins du Quebec#25 · 19 sh$143.000.0%
Caitong International Asset Management , Ltd#26 · 1 sh$8.000.0%

Funds that sold out of MSLE in Q2 2026 (7)

Held MSLE at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held MSLE in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
HRT FINANCIAL30,461 sh$171.0K
JANE STREET GROUP19,608 sh$110.4K
Monashee Investment Management12,000 sh$67.6K
Propel Bio Management10,145 sh$57.1K
AXQ CAPITAL10,096 sh$56.8K
NATIONAL BANK OF CANADA2,115 sh$11.8K
MAI Capital Management140 sh$789.00

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.